Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thoracic Malignancies × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8738 Neoplasms 6702 Carcinoma, Non-Small-Cell Lung 4900 Prostatic Neoplasms 4328 Colorectal Neoplasms 3926 Lung Neoplasms 3181 Leukemia, Myeloid, Acute 2660 Neoplasm Metastasis 2640 Multiple Myeloma 2627 Pancreatic Neoplasms 2459 Melanoma 2271 Ovarian Neoplasms 2212 Lymphoma 2212 Carcinoma, Hepatocellular 2114 Stomach Neoplasms 2001 Recurrence 1891 Head and Neck Neoplasms 1798 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1780 Lymphoma, Non-Hodgkin 1760 Leukemia 1754 Brain Neoplasms 1664 Glioblastoma 1552 Colonic Neoplasms 1523 Leukemia, Lymphocytic, Chronic, B-Cell 1502 Rectal Neoplasms 1487 Uterine Cervical Neoplasms 1422 Squamous Cell Carcinoma of Head and Neck 1397 Lymphoma, Follicular 1393 Lymphoma, Large B-Cell, Diffuse 1362 Carcinoma, Renal Cell 1342

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732430 2018-11-29

CARTAI

Taizhou Hospital

Phase 2 Unknown

Thoracic Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡